Moving towards optimized treatment for children and adolescents with juvenile idiopathic arthritis in sustained remission randomized to continue stable treatment, methotrexate withdrawal or tumor necrosis factor inhibitor withdrawal: study protocol for the Norwegian multi-center MOVE-JIA trial
旨在优化处于持续缓解期的幼年特发性关节炎患儿及青少年的治疗方案:随机分组,分别接受持续稳定治疗、停用甲氨蝶呤或停用肿瘤坏死因子抑制剂治疗:挪威多中心 MOVE-JIA 试验的研究方案
期刊:Trials
影响因子:2
doi:10.1186/s13063-026-09539-0
Hetlevik, Siri Opsahl; Lilleby, Vibke; Pesonen, Maiju; Nordal, Ellen; Rygg, Marite; Austad, Cathrine; Jonsson, Maria Karolina; Bilstad, Maria; Høiberg, Hege Kilander; Sande, Nina Krafft; Flatø, Berit; Lillegraven, Siri; Haavardsholm, Espen A; Ramanan, Athimalaipet V; Molberg, Øyvind; Bøyesen, Pernille; Aga, Anna-Birgitte